RELITRO 2.5 MG TABLET

Each tablet contains Letrozole 2.5 mg, an aromatase inhibitor. Letrozole works by reducing the production of estrogen in the body. Since certain breast cancer cells depend on estrogen for growth, lowering estrogen levels helps slow or stop the progression of the disease. In fertility treatment, lower estrogen levels stimulate the release of hormones that trigger ovulation, supporting conception efforts.

Relitro 2.5 mg Tablet is commonly used in cases such as hormone receptor–positive breast cancer, postmenopausal estrogen suppression therapy, and ovulation induction in women struggling with irregular or absent ovulation. The medication must be used strictly under medical guidance, as dosage and duration vary depending on individual health conditions and treatment objectives.

The tablet is taken orally and is generally well-tolerated when used as directed. Regular monitoring and physician follow-up are important to ensure treatment effectiveness and safety. Do not adjust the dosage without consulting your doctor. When used appropriately, Relitro 2.5 mg Tablet provides valuable support in both cancer therapy and fertility management by balancing hormone levels safely and effectively.